65 reports

Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pancreatic Cancer
  • France
  • United States
  • World
  • Forecast

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • United States
  • Market Size

Pancreatic cancer

4546 5000 3864
  • LEADING TREATMENTS FOR PANCREATIC CANCER
  • LEADING TREATMENTS FOR PANCREATIC CANCER

The prognosis of patients with pancreatic cancer remains poor; however, this clinical need will drive future market expansion and the development of several targeted therapies. This report addresses the following questions: -What are the current treatment options for patients with pancreatic cancer in each therapeutic...

  • Pancreatic Cancer
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • NewLink Genetics Corporation
  • Taiho Pharmaceutical Co., Ltd.
  • PANCREATIC CANCER THERAPEUTICS, COMMON MUTATIONS IN PANCREATIC CANCER
  • PANCREATIC CANCER THERAPEUTICS, SURVIVAL BY STAGE

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Summary Pancreatic Cancer (PC) is a disease predominately of the elderly with ~75% of PC cases being diagnosed in patient’s over 75 years old. PC proliferates rapidly, is...

  • Pancreatic Cancer
  • World
  • Forecast
  • Market Size
  • Celgene Corporation
  • PANCREATIC CANCER SURVIVAL RATE
  • PROGNOS PANCREATIC CANCER DIAGNOSIS TEST RESULT VARIANCE

Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the...

  • Artificial Intelligence
  • Healthcare
  • Hospital
  • Information Technology
  • Pancreatic Cancer

Europe Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pancreatic Cancer
  • Europe
  • France
  • Germany
  • Forecast

Pancreatic Cancer -Epidemiology Forecast to 2027 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • Italy
  • Spain

Pancreatic Cancer - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Market Shares

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Pancreatic Cancer
  • France
  • Germany
  • Italy
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Japan
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • France
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Italy
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Germany
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United Kingdom
  • Market Size

Pancreatic Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Spain
  • Market Size

" Target Atlas in Pancreatic Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline information covering commercial developments of molecular drug targets in pancreatic cancer from ##

  • Cancer
  • Pancreatic Cancer
  • STAGES AND LOCATION OF PANCREATIC CANCER
  • Staging of Pancreatic Cancer

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of...

  • Cancer
  • Pancreatic Cancer
  • Pathology

Drug Analysis: Masitinib Product Profiles masitinib : Prostate cancer masitinib : Colorectal cancer (CRC) masitinib : Asthma masitinib : Pancreatic cancer LIST OF FIGURES Figure ##: Masitinib for prostate cancer – SWOT analysis Figure ##: Datamoni

  • Colorectal Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • European Union
  • United States
  • 4.2 PANCREATIC CANCER - AN OVERVIEW
  • PANCREATIC CANCER - GLOBAL PREVALENCE

Pancreatic Cancer Therapeutics & Diagnostics Market The market is expected to grow modestly from USD 1,730 million in 2015, growing at a CAGR of 10-17%. Globally, pancreatic cancer is the 12th most common cancer in men and 11th most common cancer in women. Addiction to cigarettes and health history are considered...

  • Chemotherapy
  • Pancreatic Cancer
  • United States
  • World
  • Market Size

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U. S.

  • Cancer
  • Pancreatic Cancer
  • United States
  • Forecast
  • Market Size

Pancreatic Cancer Global Clinical Trials Review, H##, 2017 Table of Contents Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributing to Clinical Trials in

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • Pancreatic Cancer
  • World

##, ##, ##, ##, ##, ##, ##, ##, ## and ## respectively.

  • Cancer
  • Pancreatic Cancer
  • Pharmaceutical
  • Therapy

##, ##, ##, ##, ##, ##, ##, ##, ## and ## respectively.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Pharmaceutical
  • Therapy

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Pancreatic Cancer Diagnostic Tests Overview ## ## Products under Development ## ##. ##

  • Clinical Trial
  • Drug Discovery And Development
  • Pancreatic Cancer
  • United States
  • Company

Pancreatic Cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • United States
  • Product Initiative

Hoffmann-La Roche Ltd., H## 2016 ## Metastatic Pancreatic Cancer - Pipeline by Fountain Biopharma Inc., H## 2016 ## Metastatic Pancreatic Cancer - Pipeline by Gilead Sciences, Inc., H## 2016 ## Metastatic Pancreatic Cancer - Pipeline by GlaxoSmithKl

  • Cancer
  • Pancreatic Cancer
  • Therapy

Hoffmann-La Roche Ltd., H## 2016 ## Metastatic Pancreatic Cancer - Pipeline by Fountain Biopharma Inc., H## 2016 ## Metastatic Pancreatic Cancer - Pipeline by Gilead Sciences, Inc., H## 2016 ## Metastatic Pancreatic Cancer - Pipeline by GlaxoSmithKl

  • Cancer
  • Pancreatic Cancer
  • Therapy
  • Pancreatic Cancer- Recent Developments
  • NANOMABKV - PANCREATIC CANCER - PRODUCT STATUS

Pancreatic Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer - Pipeline Review, 2015" provides an overview of Pancreatic Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative...

  • Drug Discovery And Development
  • Pancreatic Cancer
  • United States
  • Company
  • GlobalData's company
  • NANOKNIFE SYSTEM - PANCREATIC CANCER
  • NANOKNIFE SYSTEM - PANCREATIC CANCER - PRODUCT DESCRIPTION

Summary AngioDynamics Inc (AngioDynamics) is a provider of medical, surgical and diagnostic devices. Its major products include peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and...

  • Clinical Trial
  • Pancreatic Cancer
  • Prostate Cancer
  • Transdermal Delivery
  • AngioDynamics, Inc.